Traws Pharma Inc (NAS:TRAW)
$ 0.6199 -0.0008 (-0.13%) Market Cap: 15.68 Mil Enterprise Value: -686,000.00 PE Ratio: 0 PB Ratio: 2.14 GF Score: 70/100

Q4 2021 Onconova Therapeutics Inc Earnings Call Transcript

Mar 17, 2022 / 08:30PM GMT
Release Date Price: $1.86 (+16.25%)
Operator

Ladies and gentlemen, thank you for standing by. Welcome to the Onconova Therapeutics Full Year 2021 Financial Results and Business Update Conference Call. (Operator Instructions) As a reminder, this call is being recorded today, March 17, 2022.

At this time, I would like to turn the call over to Avi Oler, Senior Vice President of Corporate Development and General Counsel.

Abraham N. Oler
Onconova Therapeutics, Inc. - Senior VP of Corporate Development & General Counsel

Thank you, operator. Good afternoon, everyone, and welcome to Onconova's Full Year 2021 Financial Results and Business Update Conference Call. Earlier this afternoon, we issued a press release reporting our financial results and business progress. If you have not yet seen this press release, it is available in the Investors & Media section of our website at www.onconova.com.

On today's call, you'll first hear from our President and CEO, Dr. Steve Fruchtman, who will give a high-level overview on our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot